Health Catalyst, Inc. (HCAT) - Comprehensive Stock Analysis & Investment Research
Deep dive into Health Catalyst, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Health Catalyst, Inc. Investment Summary
When evaluating whether Health Catalyst, Inc. (HCAT) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Health Catalyst, Inc. (HCAT) operates within the Technology sector, specifically in the Services-Computer Programming, Data Processing, Etc. industry. The company employs approximately 1,313 people. With a market capitalization of $171 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Health Catalyst, Inc. generates annual revenues of approximately $316 million. The company currently reports a negative net margin of -23.8%, which investors should monitor closely.
From a profitability standpoint, the company has a Return on Equity (ROE) of -39.3%, suggesting room for improvement in capital efficiency. The Return on Assets (ROA) stands at -21.1%, suggesting potential for operational improvement. The gross margin of 37.0% indicates healthy product or service economics.
Balance Sheet Strength
Examining the balance sheet health, the current ratio of 5.21x indicates excellent short-term liquidity, meaning the company can comfortably cover its near-term obligations. The debt-to-equity ratio of 0.51x indicates moderate leverage, typical for many established companies.
Cash Flow Generation
Health Catalyst, Inc. currently reports negative free cash flow of $-34 million, which may reflect heavy investment in growth or operational challenges. Operating cash flow stands at $-19 million, indicating the company is consuming cash in its operations.
Valuation Analysis
The company currently has negative earnings, resulting in no meaningful P/E ratio. This is common for growth companies investing heavily in expansion or those facing temporary headwinds. The price-to-book ratio stands at 0.52x, potentially indicating undervaluation or market concerns about asset quality.
AI-Powered Price Predictions
Our AI models continuously analyze Health Catalyst, Inc. to identify potential price movements. Subscribe to Intratio Premium to unlock detailed AI-powered price predictions for 7, 30, and 90-day horizons.
Investment Considerations
When determining whether Health Catalyst, Inc. is a suitable investment, consider your investment objectives, risk tolerance, and time horizon. As a small-cap stock, Health Catalyst, Inc. may offer higher growth potential but also carries elevated volatility and risk.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Corporate Identity
Health Catalyst, Inc. (Stock Symbol: HCAT) is a prominent company operating within the Technology sector, with a specific focus on the Services-Computer Programming, Data Processing, Etc. industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
The organization employs approximately 1,313 professionals, indicating a well-established company with meaningful operational scale and the human resources necessary to compete effectively in its markets.
Market Classification
With a market capitalization of $171 million, Health Catalyst, Inc. is classified as a small-cap stock. Small-cap companies often represent emerging businesses with substantial growth potential. While these investments typically carry higher volatility, they can offer significant upside for investors willing to accept greater risk.
Sector & Industry Context
Operating within the Technology sector, Health Catalyst, Inc. is subject to the unique dynamics, opportunities, and challenges that characterize this segment of the economy. The technology sector is known for rapid innovation, high growth potential, and competitive intensity. Companies in this sector must continuously invest in research and development to maintain their competitive edge.
Revenue & Growth Analysis
Health Catalyst, Inc. generates annual revenues of $316 million , representing an emerging company in its growth phase. While smaller in scale, such companies often offer higher growth potential as they capture market share and expand their operations.
Profitability Analysis
The company achieves a -23.8% net profit margin, indicating the company is currently operating at a loss. This could reflect heavy growth investments, restructuring costs, or fundamental business challenges that require careful evaluation.
Gross profit margin stands at 37.0%, a moderate margin common in manufacturing, retail, or distribution-heavy businesses where competition or cost structures limit pricing flexibility.
Operating margin is -26.4%, suggesting high operating expenses relative to revenues, which may reflect growth investments or operational inefficiencies.
Market Valuation
Current market capitalization stands at $171 million . This small-cap classification typically represents higher-growth, higher-risk opportunities. Small-cap stocks can be more volatile but may offer substantial returns if the company successfully executes its growth strategy.
Return on Investment Metrics
Return on Equity (ROE) measures -39.3%, indicating negative shareholder returns, typically resulting from operating losses or exceptional write-downs.
Return on Assets (ROA) stands at -21.1%, indicating lower asset efficiency that may reflect industry norms or opportunities for operational improvement.
Return on Invested Capital (ROIC) measures -22.4%, which may indicate returns below the cost of capital, potentially destroying shareholder value over time if sustained.
Cash Flow Generation
Free cash flow of $-34 million indicates the company is currently consuming more cash than it generates, which may reflect heavy growth investments, working capital needs, or operational challenges.
Operating cash flow reaches $-19 million . Operating cash flow represents the cash generated from core business operations before capital investments, providing insight into the sustainability of the company's business model.
Strategic Market Position
Health Catalyst, Inc. strategically competes in the highly dynamic Services-Computer Programming, Data Processing, Etc. marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Health Catalyst, Inc. operates within the fast-evolving technology sector where competitive dynamics are shaped by innovation cycles, platform economics, and network effects. Technology companies must continuously invest in R&D to maintain relevance, while also defending against disruption from startups and adjacent market entrants. Success in this sector often requires achieving critical scale or establishing defensible intellectual property positions.
Operational Efficiency
The company currently shows negative free cash flow of $-34 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a 37.0% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.
Operating margin of -26.4% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.36x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 5.21 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.